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Background: Relevant and psychometrically sound needs assessment tools are necessary for accurate assessment
of haematological cancer survivors unmet needs. No previous study has developed nor psychometrically evaluated
a comprehensive needs assessment tool for use with population-based samples of haematological cancer survivors.
This study aimed to assess the validity and reliability of the Survivor Unmet Needs Survey (SUNS) with
haematological cancer survivors.
Methods: The relevance, content and face validity of the SUNS to haematological cancer survivors was assessed
using qualitative interviews. Psychometric evaluation was conducted using data collected from haematological
cancer survivors, aged 18–80 years at recruitment and recruited from four Australian cancer registries. Construct,
convergent and discriminant validity; internal reliability and floor and ceiling effects were assessed. A second survey
was completed by a sub-sample of survivors recruited from two of the four registries to assess test-retest reliability.
Results: Results from 17 qualitative interviews confirmed the relevance, face and content validity of the original
items of the SUNS for use with haematological cancer survivors. Overall, 1,957 eligible haematological cancer
survivors were contacted by the cancer registries. Of these 1,280 were sent a survey, and 715 returned a survey
(37% of eligible survivors contacted and 56% of survivors sent a survey). A total of 529 survivors completed all
89 items of the SUNS and were included in the exploratory factor analysis. Exploratory factor analysis supported the
original five-factor structure of the SUNS. Evidence for convergent validity was established, with all five domains of
the SUNS illustrating a moderate positive correlation with all three subscales of the Depression Anxiety and Stress
Scale (DASS-21). All Cronbach’s alpha values were above 0.9 and all corrected item-total correlations were
acceptable (>0.2). Criteria for discriminant validity was not met, with only 10 of the 15 (67%) a-priori hypotheses
supported. Test-retest reliability was acceptable for 40 of the 89 items (45%) and for three of the five domains.
Significant floor effects were evident for all five domains.
Conclusions: The SUNS demonstrates evidence for multiple features of validity and reliability as a measure of
unmet needs for haematological cancer survivors. However, evidence supporting some psychometric properties
was limited.
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Haematological cancers are cancers of the blood or im-
mune system [1-3]. Research has estimated haematological
cancers to be the fourth most commonly diagnosed cancer
type in the economically developed world [4]. Survival
rates for some haematological cancers are increasing
across several countries [5-7].
Haematological cancers are a unique and diverse sub-
group of cancers. They can range from chronic and in-
curable, to acute and aggressive [3]. Treatment is equally
variable and may include “watchful-waiting”, chemother-
apy, radiotherapy, immunotherapy and bone marrow
transplant [3,8]. Like other cancers, haematological can-
cers impact on multiple aspects of a person’s life, for
some resulting in tiredness and fatigue [9,10], anxiety
and depression [9,11] and social impacts including lim-
ited leisure time [12], missing family and social events
[13], and employment-related outcomes [13-15].
Supportive care that is responsive to cancer survivors’
physical, emotional, psychological, informational and so-
cial needs is necessary to achieve optimal cancer care
[16,17]. Needs-based assessment provides a means of iden-
tifying patient concerns and the level of assistance patients
perceive they need to address their concerns [18-20]. Data
from needs-based assessments can be used in clinical
practice to enhance patient-provider communication by
efficiently identifying patient problems and directing
appropriate care and services to patients [21]. Population-
based assessment of needs can be used to allocate re-
sources, improve care and direct services towards the
patient-identified areas where further assistance is most
needed [17,21,22].
Accurate and systematic identification of cancer survi-
vors’ needs is necessary to ensure appropriate supportive
care is provided [22,23]. Consequently, needs-based as-
sessment tools that are comprehensive, relevant and have
strong psychometric properties are essential. Previous re-
search has used various criteria to evaluate self-report
scales [24-26], including key psychometric properties such
as content validity, internal consistency, criterion validity,
construct validity, reproducibility, responsiveness, floor
and ceiling effects and interpretability [24].
Two comprehensive, cancer-survivor specific needs as-
sessment tools have been developed and psychometrically
evaluated: (1) the Cancer Survivors’ Unmet Needs meas-
ure (CaSUN) [27], and (2) the Survivor Unmet Needs
Survey (SUNS) [28]. The CaSUN was psychometrically
assessed with 353 disease-free cancer survivors, diagnosed
in the previous 1 to 15 years and recruited from two
Australian hospitals [27]. The majority (97%) of survivors
who completed the CaSUN had been diagnosed with
breast, gynaecologic, colorectal or prostate cancer [27].
The CaSUN was found to have good acceptability, internal
consistency and face, content and construct validity;however item test-retest was low [27]. The SUNS was psy-
chometrically evaluated with a heterogeneous sample of
550 cancer survivors, including haematological cancer sur-
vivors, diagnosed 1–5 years previously and recruited from
one Canadian cancer registry [28]. The SUNS was found
to have high acceptability, item test-retest reliability, in-
ternal consistency and face, content and construct validity
[28]. Neither of these tools has been psychometrically
assessed for use in population-based samples of haemato-
logical cancer survivors. Given the variable nature and di-
verse treatment regimens of haematological cancers, the
relevance and appropriateness of such tools for use with
this population needs to be evaluated.
The SUNS was considered the most relevant of the
two cancer survivor specific needs assessment instru-
ments for psychometric evaluation with a population-
based sample of haematological cancer survivors. Unlike
the CaSUN, the SUNS illustrates acceptable item test-
retest reliability and was psychometrically evaluated with
a population-based sample of cancer survivors that in-
cluded a larger proportion of haematological cancer sur-
vivors [28]. Despite the strong psychometric properties
of the SUNS several important properties have not been
assessed, including, convergent validity, discriminant val-
idity (known-groups validity), test-retest reliability at the
domain level, floor and ceiling effects, responsiveness
and criterion validity.
This study aimed to evaluate the psychometric properties
of the SUNS for use with adult haematological cancer sur-
vivors. This evaluation consisted of two phases: (1) qualita-
tive evaluation of the relevance, content and face validity;
and (2) quantitative survey of haematological cancer survi-
vors for psychometric evaluation. This study also extended
on the original psychometric evaluation of the SUNS by
assessing convergent and discriminant validity, floor and
ceiling effects and test-retest reliability at the domain level.
Methods
The measure
The Survivors Unmet Needs Survey (SUNS) measures can-
cer survivors’ unmet needs over the last month, using 89
items across five domains: Financial Concerns (11 items),
Emotional Health (33 items), Access and Continuity of
Care (22 items), Information (8 items) and Relationships
(15 items) [28]. Each item is scored from zero (no unmet
need) to four (very high unmet need) [28].
Phase 1: Relevance, face and content validity
The relevance, face and content validity of the SUNS
was assessed by two qualitative evaluations.
Cultural relevance
The wording of the SUNS was reviewed by a conveni-
ence sample of Australian researchers and members
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search team. Four items were reworded as a result of
this process. The amended version of the SUNS was
then reviewed by two native Canadians, who were also
known to the research team. The two Canadian’s consid-
ered the changes appropriate. A summary of this process
is reported elsewhere [29].
Relevance to target population
A convenience sample of 17 haematological cancer sur-
vivors (consent rate 41%) completed a semi-structured
interview (average length 26 minutes) assessing their
most prevalent unmet needs. Most survivors were male
(59%; n = 10), diagnosed with non-Hodgkin’s lymphoma
(59%; n = 10) and almost half were aged between 50 and
59 years at time of diagnosis (47%; n = 8). The interviews
did not identify any additional concerns that were out-
side the scope of the original items; therefore no new
items were included. All participants taking part in this
interview study provided written informed consent. Hu-
man Research Ethics approval for this interview study
was obtained from the University of Newcastle Human
Research Ethics Committee and the relevant ethics com-
mittee associated with the specific cancer registry.
Phase 2: Psychometric evaluation of the SUNS
Sample
A cross-sectional sample of haematological cancer survi-
vors, aged between 18 and 80 years at time of recruitment
were selected from four Australian state population-based
cancer registries.
Procedure
The standard recruitment procedures of each registry
were used. The first registry conducted a one-off cross-
sectional survey. On behalf of the researchers, survivors
were mailed a questionnaire package from this cancer
registry [30].
The remaining three registries employed a rolling re-
cruitment method, where survivors were identified and
approached on an ongoing basis between September 2011
and July 2012. A passive clinician consent model (clinician
notification) [31,32] was used by these three registries. Eli-
gible survivors were contacted by the registries via mail
unless their clinician had previously notified the registry
not to contact their patient. Survivors who consented to
the registry passing on their contact details to the re-
searchers were mailed a questionnaire package from the
researchers. Non-responders were mailed a second ques-
tionnaire package approximately 4 weeks later, and con-
tacted via telephone after a further 4 weeks.
Return of a completed survey was taken as voluntary
consent to participate. Ethics approval was obtained from
the University of Newcastle Human Research EthicsCommittee and the relevant ethics committees associated
with each registry.
Measures
In addition to the SUNS, the following survivor informa-
tion was used.
Patient, disease and treatment characteristics For
consenting survivors data relating to their age, sex, post-
code or location at diagnosis, cancer type and date of diag-
nosis were obtained from the cancer registries. Cancer
recurrence and current treatments received were collected
via self-report. De-identified data for non-participants
were collected from all four cancer registries and de-
identified data for all participants were collected from two
cancer registries and included: age-group at diagnosis, sex,
postcode or location at diagnosis and cancer type. Identi-
fied data for consenting survivors from the other two
registries were used for participant and non-participant
comparisons. Chi-squared analyses were used to compare
characteristics of participants and non-participants.
Depression, anxiety and stress The Depression Anxiety
and Stress Scale (DASS-21) is a self-report measure of de-
pression, anxiety and stress over the past week, with three
subscales each consisting of seven items [33]. Respondents
rate each item on a scale from 0 (“not at all”) to 3 (“very
much”) [34]. A total subscale score is calculated by sum-
ming all items in a subscale and multiplying by two [33].
A higher score represents a higher level of the emotional
state. Calculation of subscale scores requires completion
of at least six of the seven subscale items [35]. The DASS-
21 has illustrated validity and reliability in both clinical
and non-clinical populations [33,34,36,37].
Statistical analysis
Construct validity
The distribution, frequencies and number of missing
values for each of the 89 items of the SUNS were assessed.
Items with more than 10% missing data or with more than
90% of responses occurring on only one of the response
options were considered for potential exclusion.
Exploratory Factor Analysis (EFA) was used to assess the
construct validity of the SUNS for use in a haematological
cancer survivor population [38]. The principal factors
method of EFA was employed due to the skewed distribu-
tion of the SUNS data [39,40]. The number of factors to
retain was determined using the following three methods:
(1) Kaiser-Guttman Criterion (Eigen value greater than
one), (2) the break-point in the scree plot and (3) parallel
analysis [39,40]. Multiple factor analyses were produced
based on the results suggested by these three methods
[40]. Results from all factor analyses were compared. The
final factor structure was determined as having (i) at least
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considered conceptually relevant [41]. The number of
cross-loadings was also examined. Original psychometric
evaluation of the SUNS found high correlations between
several factors [28]. To allow for correlations between the
factors, a promax oblique rotation was used to simplify the
factor structure [39-41]. Listwise deletion removed obser-
vations with any missing data on the SUNS.Convergent validity
An association between unmet needs and anxiety, depres-
sion and/or stress has previously been found in heteroge-
neous samples of cancer survivors [18,42-44] and, to a
lesser extent, haematological cancer survivors [9]. Spear-
man’s rank correlations between the final factor scores of
the SUNS and anxiety, depression and stress scores on the
DASS-21 were calculated. Based on previous criteria used
to assess the psychometric properties of self-report scales,
a correlation coefficient above 0.4 was considered accept-
able evidence of convergent validity [25].Known-groups (discriminant) validity
Compared to their counterparts, a higher level of some
unmet needs has been found for cancer survivors: report-
ing not being in remission (stable, recurrent and metastatic
disease) [18,45]; diagnosed at a younger age [29,42,45-50];
and receiving some cancer treatments [43,45,46,51]. Based
on this previous research it was hypothesized that median
domain scores would be higher for: (1) survivors reporting
a disease recurrence vs. survivors not reporting a disease
recurrence; (2) survivors aged younger than 60 years at
diagnosis vs. survivors aged 60 years or older at diagnosis;
and (3) survivors currently receiving active treatment (in-
cluding, chemotherapy, radiotherapy, bone marrow/stem
cell transplant or harvest, hormone, antibody and targeted
therapy) vs. those not receiving active treatment.
Domain scores were calculated by summing all items in
a domain and dividing by the number of non-missing
items for participants who answered more than 70% of
items in a domain [29]. Due to the non-normal distribu-
tion of the data participant domain scores were compared
by recurrence, age group at diagnosis and treatment status
using the Wilcoxon rank sum test. Known-groups validity
was considered acceptable if ≥ 75% of the proposed hy-
potheses were supported [24].Internal reliability
Corrected item –total correlations above 0.2 [25,52] and
Cronbach’s alpha between 0.7 and 0.95 [24] were consid-
ered acceptable indicators of internal reliability. Case-
wise deletion removed observations with missing data.Test-retest reliability
Survivors who were recruited from two of the cancer
registries, returned a completed initial survey after 4
April 2012, and consented to future contact from the re-
searchers, were sent a second copy of the SUNS, 7–14
days after the receipt of their original survey. This time
period was chosen to reduce recall bias and the likeli-
hood of a change occurring in the participant’s level of
reported unmet needs [24]. Item test-retest reliability
was assessed for each item using weighted Kappa, apply-
ing quadratic weighting [53]. A kappa coefficient >0.6
was considered acceptable [54]. Test-retest reliability at
the domain level was assessed using intra-class correl-
ation coefficients (ICCs) between mean domain scores
from Time 1 and Time 2. ICCs ≥0.7 were considered ac-
ceptable [24].
Floor and ceiling effects
The percentage of respondents reporting the lowest and
highest possible scores for each domain were calculated.
Domains where >15% of respondents obtained the low-
est or highest possible scores were considered indicative
of floor and ceiling effects [24].
Sample size
Based on previous recommendations, a sample size of
400 survivors was considered adequate for factor ana-
lysis and estimation of reliability and validity coefficients
[55-57], while a sample size of at least 50 participants
has been suggested for assessing adequate levels of test-
retest reliability [24].
Results
Response rates
A total of 1,957 eligible survivors were contacted by
the cancer registries and 1,280 were sent a survey.
Seven hundred and fifteen survivors returned a com-
pleted survey (37% of all eligible survivors contacted
and 56% of eligible survivors sent a survey); of these,
529 (74%) completed all 89 items of the SUNS. A total
of 146 eligible survivors were mailed a second copy of
the SUNS; of these, 125 returned a completed survey
(86%).
Participant and non-participant characteristics
The majority of participants were diagnosed with Non-
Hodgkin’s lymphoma (59%; n = 397) and most were
male (n = 393; 58%). Approximately one third were aged
between 60 and 69 years at diagnosis (n = 236; 35%).
The median time since diagnosis was 35 months (quar-
tile 1 = 20, quartile 3 = 51). Participants and non-
participants were statistically significantly different in
regards to age-group at diagnosis and cancer type
(Table 1).
Table 1 Statistically significant differences between participant and non-participant characteristics
Characteristics Participants
(n = 715)a
Non-participants
(n = 1242)a
Chi-squared χ2(df), p
N % N %
Cancer Type 11.05(3), 0.011
Non-Hodgkin’s Lymphoma (NHL) 397 59% 667 56%
Leukemia 129 19% 194 16%
Myeloma 108 16% 203 17%
Other lymphoma 42 6.2% 123 10%
Age at diagnosis 25.12(4), <0.001
15-39 54 8.0% 169 14%
40-49 71 11% 144 12%
50-59 179 26% 263 22%
60-69 236 35% 341 29%
70+ 136 20% 270 23%
aTotals may not equal sample size due to missing values.
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Construct validity
The distributions of all items were skewed to the right.
The median for all 89 items ranged from 0 (SD = 0.72)
to 1 (SD = 1.28). The full range of response options were
used for every item. No items had response options
which included 90% or more of the distribution. Missing
data for the 89 items ranged from 2.0% to 5.3%.
Five factor structures were assessed: a 7-factor model
based on the Kaiser criteria; a 3, 4, 5 and 6 factor model
based on the scree plot; and a 5-factor model based on
the parallel analysis. After rotation, the 5-factor model
was deemed most appropriate, as all factors contained
more than 3 items, the highest factor loading of each
item was >0.3 [39] and the structure was considered the
most conceptually relevant. Cross-loadings were present
for all five models.
The factor loadings of the final 5-factor model are
shown in Table 2. The 5-factor model closely reflected
the original factor structure of the SUNS [28]. All items
from the original Information, Access and Continuity of
Care and Emotional Health domains loaded highest on
factor 5, factor 2 and factor 1, respectively. All but two
of the 11 items from the original Financial Concerns do-
main loaded highest on factor 4. Two items originally
from the Financial Concerns domain loaded more highly
with all items from the Access and Continuity of Care
domain. Twelve of the 15 items from the original Rela-
tionships domain loaded together on factor 3. Three
items originally from the Relationships domain loaded
highest on factor 1, with all items from the original Emo-
tional Health domain. Conceptually these five items
were most consistent with the original domains of the
SUNS. Additionally, the factor loadings of these five
items on their original domains was higher than thepredetermined criterion of 0.3. Most cross-loadings in
the 5-factor model occurred between items from the ori-
ginal Relationships domain cross-loading with items
from the original Emotional Health domain. Based on
statistical results and conceptual relevance, the original
factor structure of the SUNS was identified as appropri-
ate for use with haematological cancer survivors.
Known-groups (discriminant) validity
As shown in Table 3, haematological cancer survivors
reporting a disease recurrence compared to those not
reporting a recurrence, had higher median domain
scores for the Financial Concerns, Access and Continuity
of Care and Emotional Health domains. Median scores
for all five domains were higher for younger (<60 years
at diagnosis) than older (≥60 years at diagnosis) survi-
vors. Median domain scores for the Financial Concerns
and Emotional Health domains were higher for survivors
currently receiving treatment relative to those not re-
ceiving treatment.
Convergent validity
All five domains of the SUNS obtained a correlation co-
efficient above 0.4 with all three subscales of the DASS-
21. Correlation coefficients ranged from 0.44 to 0.73.
Internal consistency
All corrected item-total correlations were above 0.2,
ranging from 0.61 to 0.88. All five domains had high
Cronbach’s alpha values (>0.9) (Table 4).
Test-retest reliability
Weighted Kappa coefficients between item responses from
Time 1 and Time 2 (mean of 28 days, SD = 16.1 days)
ranged from 0.25 to 0.76 (M= 0.58; SD = 0.09). Forty items
Table 2 Factor loadings for the 89 items of the Survivor Unmet Needs Survey (SUNS)
Domains from original
measure
Item Factor
1
Factor
2
Factor
3
Factor
4
Factor
5
Information Finding information about what signs to look for and when to be
concerned
0.34 0.51
Knowing which sources of information to trust 0.59
Finding information about all my treatment choices, including no treatment
at all
0.38 0.61
Finding information about complementary or alternative therapies 0.31 0.51
Dealing with fears about cancer spreading 0.32 0.62
Dealing with worry about whether the treatment has worked 0.33 0.59
Dealing with feelings of worry (anxiety) between follow-ups 0.43 0.55
Dealing with not feeling sure that the cancer has gone 0.34 0.49
Financial concerns Worry about earning money 0.75
Having to take a pension or disability allowance 0.76
Paying household bills or other payments 0.84
Adapting to living on a pension or disability allowance 0.82
Paying non-medical costs related to my cancer (travel, accommodation,
special foods, etc.)
0.62
Finding what type of financial assistance is available and how to obtain it 0.46
Finding car parking that I can afford at the hospital or clinic 0.43* 0.34
Understanding what is covered by my medical insurance or benefits 0.43* 0.30
Knowing how much time I would need away from work 0.56
Doing work around the house (cooking, cleaning, home repairs etc.) 0.39
Doing yard work (lawn mowing, etc.) 0.33 0.39
Access and continuity
of care
Finding information about who I should contact if I have a problem or
concern
0.50
Finding information about cancer and its effects in a way I can understand 0.52 0.41
Finding out what is involved in follow-up care 0.54 0.37
Making sure my family doctor could get information from specialists 0.65
Making sure I was treated in a hospital or clinic that was as physically
pleasant as possible
0.67
Having access to cancer services close to my home 0.50
Having access to cancer services at night and on weekends 0.71
Getting appointments with my family doctor quickly enough 0.63
Getting appointments with specialists quickly enough (oncologist,
surgeon etc.)
0.79
Getting follow-up tests quickly enough 0.85
Getting test results quickly enough 0.79
Having access to care from other health specialists (e.g. dieticians,
physiotherapists, occupational therapists)
0.68
Making sure I had choices about which hospital or clinic I could go to 0.75
Making sure health care workers had access to my medical information
when planning services for me
0.85
Feeling comfortable in the waiting room 0.63
Making sure I had enough time to ask my doctor or nurse questions 0.81
Making sure all my health care workers had all the medical files related to
my cancer care
0.87
Getting the health care team to attend promptly to my physical needs 0.78
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Table 2 Factor loadings for the 89 items of the Survivor Unmet Needs Survey (SUNS) (Continued)
Finding health care professionals who were friendly and could have a joke
with me
0.84
Making sure the health care team understood and was aware of my feelings
and emotional needs
0.70
Making sure I was treated like a person, not just another case 0.77
Understanding the information I was given 0.67
Relationships Dealing with the way other people react to my new priorities and my
different outlook on life
0.58
Dealing with losses and changes in my relationships 0.48
Telling others how I was feeling physically 0.37 0.50
Telling others how I was feeling emotionally 0.42 0.49
Talking to my family and friends about how they were feeling 0.35 0.44
Finding someone to talk to who understands and has been through a
similar experience
0.36 0.45
Dealing with people who expect me to be “back to normal” 0.47 0.52
Dealing with people not knowing what to say or how to behave 0.35 0.53
Dealing with people who expect me to feel happy or relieved when
treatment has ended
0.49* 0.43
Dealing with people not understanding what I’m going through 0.61* 0.47
Dealing with how people are not able to cope with my illness 0.42 0.51
Dealing with people accepting that having cancer has changed me as a
person
0.52 0.54
Dealing with reduced support from others when treatment has ended 0.38 0.46
Dealing with strains in relationships 0.50* 0.39
Finding someone to listen to me even if there is nothing they can do 0.47 0.48
Emotional Health Dealing with people not understanding how my physical abilities have
changed
0.54 0.37
Dealing with feeling like I am a burden to my family and friends 0.60
Dealing with feeling depressed 0.79
Dealing with feeling tired 0.73
Dealing with feeling stressed 0.76
Dealing with feeling worried (anxious) 0.78
Dealing with feeling lonely 0.61
Dealing with feeling vulnerable 0.76
Dealing with worry about the emotional well-being of my family 0.64
Dealing with grief and loss 0.70
Dealing with feelings about death and dying 0.78
Dealing with not feeling able to set future goals or make long-term plans 0.82
Dealing with losing confidence in my own abilities 0.87
Dealing with feeling a loss of control 0.91
Coping with feelings of despair 0.88
Coping with feeling like a different person 0.83
Dealing with not feeling happy or relieved when treatment has ended 0.69
Dealing with not being able to feel ‘normal’ 0.84
Trying to stay positive 0.84
Trying to keep a sense of hope 0.84
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Table 2 Factor loadings for the 89 items of the Survivor Unmet Needs Survey (SUNS) (Continued)
Dealing with feeling guilty about what I have put others through 0.78
Dealing with being told I had cancer 0.63
Wanting to reflect on what I have achieved 0.66
Dealing with not wanting to do the things I used to do 0.83
Knowing how to relax 0.79
Dealing with feelings of isolation 0.70
Coping with having a bad memory or lack of focus 0.79
Dealing with changes in how my body appears 0.67
Dealing with changes in my physical ability 0.78
Coping with going back into the ‘real’ world 0.73
Coping with things not going back to how they were before I had cancer 0.85
Dealing with missing important events like holidays 0.70
Support for finding meaning or new purpose in life 0.73
*Items loaded highest on a factor that was not their original domain. However, based on conceptual relevance and that all of these items loaded >0.3 on their
original domain all of these items were kept within their original domain.
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liability. ICC’s between mean domain scores at Time 1
and Time 2 ranged from 0.61 to 0.77 (Financial Concerns
ICC = 0.61, 95% CI: 0.48, 0.71; Access and Continuity of
Care ICC = 0.68, 95% CI: 0.57, 0.77; Relationships ICC =
0.72, 95% CI: 0.62, 0.79; Information ICC = 0.73, 95% CI:
0.63, 0.81; Emotional Health ICC = 0.77, 95% CI: 0.68, 0.83).
Floor and ceiling effects
Floor effects were observed for all five domains. Few
ceiling effects were observed (Table 4).
Discussion
The study results provide initial support for the SUNS as a
suitable measure of unmet needs in adult haematological
cancer survivors. Qualitative interviews with members of
the target population verified the relevance of the items
and supported the face and content validity of the measure.Table 3 Median domain scores of haematological cancer surv
and current treatment
Cancer recurrence A
Yes No/unsure <60 years
Domain n Median n Median p-valuea n Media
Information 149 0.38 499 0.38 0.13 291 0.63
Financial concerns 151 0.36 502 0.18 0.02* 293 0.36
Access and continuity
of care
154 0.14 508 0.09 0.01* 295 0.14
Relationships 154 0.33 509 0.27 0.25 293 0.53
Emotional Health 155 0.68 509 0.33 0.02* 294 0.55
*Statistically significant at 5% significance level, confirming original hypothesis for k
ap-value from Wilcoxon rank sum test.Quantitative analyses demonstrated strong psychometric
properties, across multiple aspects of validity and reliabil-
ity. However, evidence for some areas of reliability and val-
idity were limited and require further investigation.
The original 5-factor structure of the SUNS was deemed
most statistically and conceptually appropriate for use
with haematological cancer survivors. However, the results
from the factor analysis showed several discrepancies rela-
tive to the structure of the original SUNS. In particular
three items originally from the Relationships domain
loaded highest with items from the original Emotional
Health domain. The majority of cross-loadings were also
found between items from the original Relationships do-
main with items from the Emotional Health domain. It is
likely that emotional and relationship needs are highly re-
lated; these domains had a high correlation (rs = 0.848) in
the original psychometric evaluation of the SUNS [28]. Fu-
ture research should further evaluate the appropriatenessivors in relation to cancer recurrence, age at diagnosis
ge at diagnosis Current treatment of chemotherapy,
radiation, bone marrow/stem cell
harvest/transplant, hormone or antibody)
≥60 years Yes No
n n Median p-valuea n Median n Median p-valuea
350 0.13 <0.001* 147 0.50 525 0.25 0.07
353 0.09 <0.001* 149 0.36 526 0.18 0.005*
356 0.05 <0.001* 152 0.18 532 0.09 0.05
358 0.07 <0.001* 151 0.40 533 0.27 0.28
357 0.21 <0.001* 151 0.58 534 0.30 0.008*
nown-groups (discriminant) validity.
Table 4 Cronbach’s alpha coefficient and percentage of participants reporting the lowest and highest possible score
for each of the five domains of the Survivor Unmet Needs Survey (SUNS)
Domain
Number of participants
answering all domain
itemsa
Cronbach’s
alpha
Number of participants
answering >70% of
domain itemsb
n (%)
lowest
score
n (%)
highest
score
Median (First Quartile
and third Quartile)
Information 652 0.93 686 267 (39) 0 (0.0) 0.38 (0.0, 1.14)
Financial
concerns
650 0.92 689 267 (39) 2 (0.3) 0.18 (0.0, 0.82)
Access and
continuity of care
647 0.97 698 285 (41) 1 (0.1) 0.09 (0.0, 0.55)
Relationships 680 0.97 698 252 (36) 3 (0.4) 0.27 (0.0, 1.07)
Emotional health 625 0.99 698 173 (25) 1 (0.1) 0.36 (0.03, 1.21)
aParticipants answering all items in the domain and included in the calculation of Cronbach’s alpha.
bParticipants answering >70% of items in a domain and included in the calculation of floor and ceiling effects.
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atological cancer survivors.
While most (10 out of 15; 67%) of our hypotheses re-
lating to known-groups validity were supported, the
scale did not meet the specified criteria for acceptable
known-groups validity [24]. Three of our five hypotheses
relating to the expected differences in domain scores be-
tween survivors receiving treatment, compared with
those not receiving treatment, were not supported. It is
possible that only specific treatment types affect cancer
survivor unmet needs. For instance, previous studies
have found an association between cancer survivor un-
met needs and chemotherapy [43,45,46] and radiother-
apy [45,46,51] treatment, while a study of multiple
myeloma survivors found no difference in the supportive
care needs of survivors who had received a bone marrow
transplant compared to those who did not receive this
treatment [9]. We were unable to compare the unmet
needs of survivors by individual treatment types due to
the small number of survivors currently receiving each
individual treatment type.
Internal consistency was high with all corrected item-
total correlations above 0.6 and all Cronbach’s alpha
values above 0.9. However, it is possible that the high
Cronbach’s alpha values reflect some redundancy within
the scale’s items [24]. This seems particularly likely for
the domains of Access and Continuity of Care, Relation-
ships and Emotional Health, which all demonstrated
Cronbach’s alpha values above the recommended criteria
of 0.95 [24]. This finding is consistent with the results
from the original psychometric evaluation of the SUNS
[28]. The Cronbach’s alpha values for these three do-
mains may have also been inflated due to the large num-
ber of items (≥15) within each of the domains [24].
Consequently, a shorter scale may be warranted. At 89
items, this seems reasonable, particularly if this scale is
to be routinely applied in research and clinical practice.
Development of the Short Form SUNS (SF-SUNS) witha large, heterogeneous sample of Canadian cancer survi-
vors has recently been conducted [58]. It is recommended
that future studies assess the validity and reliability of the
SF-SUNS with haematological cancer survivors.
Unfortunately, the majority of items (55%) illustrated
low test-retest reliability. These items may lack stability
and therefore may not be appropriate for detecting
changes in these needs over time. However, the mean
Kappa statistic for items in this study was higher than the
mean Kappa statistic reported for item test-retest of the
CaSUN (0.58 vs. 0.13) [27], which has previously been
used to assess the unmet needs of haematological cancer
survivors [9,49]. Additionally, test-retest reliability at the
domain level was not acceptable for two domains. It is
possible that the time frame between survivors returning
the initial survey and test-retest survey (mean = 28 days)
was too long. As the SUNS assesses unmet needs over the
past month, it is possible that survivors experienced a true
change in the level of some of their unmet needs. Further
research utilising a shorter time period between initial and
follow-up surveys is needed to confirm the test-retest reli-
ability of the SUNS for haematological cancer survivors.
Floor effects were present for all five domains, indicat-
ing that most survivors were experiencing low levels of
unmet needs across all five domains. Consequently, the
ability of the SUNS to detect improvements in haemato-
logical cancer survivors’ unmet needs may be impaired,
thus impacting on the responsiveness of the scale [24].
Floor effects are not uncommon for cancer specific
needs assessment measures [18,52]. However, this may
not be a limitation of the scale but may instead be an ac-
curate reflection that many cancer survivors are in fact
doing well and have few unmet needs. This is a possi-
bility, with almost a quarter (21%) of Australian and
Canadian haematological cancer survivors reporting no
unmet needs on all 89 items of the SUNS in a previous
study conducted by the authors [29]. Alternatively, the
floor effects may also be influenced by possible sampling
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needs may be less likely to participate in research.
We conducted a thorough and rigorous psychometric
evaluation of the SUNS. However, there were some limi-
tations. Due to the cross-sectional design, the predictive
validity and responsiveness of the scale were unable to
be assessed. Future research should conduct longitudinal
studies with haematological cancer survivors to confirm
these other psychometric properties of the SUNS. Criter-
ion validity was also not assessed due to the lack of a
gold standard needs assessment tool. Despite the inclu-
sion of a qualitative component to our psychometric
evaluation, survivors were not asked to review the rele-
vance of each individual item of the SUNS. Instead, an
open-ended interview was conducted to discuss survi-
vors’ most prevalent/important unmet needs. To further
strengthen the content validity of the SUNS for this
population, the relevance of each individual item should
be confirmed via direct feedback from haematological
cancer survivors.
Study limitations include the low response rate (37% of
all eligible survivors contacted and 56% of all eligible
survivors sent a survey). However this is consistent with
previous registry-based studies that have reported low re-
sponse rates of 49% of a large heterogeneous sample of
Canadian cancer survivors [28], 43% of a sample of non-
Hodgkin’s lymphoma survivors [59], 41% of a large hetero-
geneous sample of Australian cancer survivors [45], 34%
of a large heterogeneous sample of America cancer survi-
vors [60] and 8% of adolescent and young adult cancer
patients [31]. In an effort to overcome this limitation, mul-
tiple efforts were made to increase the response rates of
haematological cancer survivors approached for this study.
Strategies included assessing the effectiveness of a tailored
invitation letter to improve response rates to survivors re-
cruited from Registry A [30], and the inclusion of several
evidence-based strategies for increasing questionnaire re-
sponse rates for survivors recruited from Registries B, C
and D, such as the use of multiple reminders to non-
responders and reducing the length of the survey sent
to survivors [61]. In addition, non-participant and par-
ticipant age at diagnosis and cancer type were statisti-
cally significantly different. These limitations may affect
the generalizability of these results to the entire popula-
tion of haematological cancer survivors.
Conclusions
Needs-based assessment is a vital step in achieving optimal
supportive care. However, no previous multi-dimensional
needs assessment tool has been psychometrically evaluated
for use with a population-based sample of haematological
cancer survivors. The present study fills this gap by identi-
fying the SUNS as a suitable measure of unmet needs in
haematological cancer survivors. This study also extendson the original psychometric evaluation of the SUNS by
assessing additional psychometric properties, including
convergent and known-groups validity, and floor and ceil-
ing effects. In the future, large-scale longitudinal studies
should assess responsiveness, predictive validity and test-
retest reliability, and also confirm the factor structure of
the SUNS with haematological cancer survivors.
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